Program Information
Session Highlights for March 6 and 7
March 6, 2006
09:00-12:30 - Graduates Session
With Speakers from the DIA and National Health Authorities to discuss:
- Global DIA Activities
- Drug Development and Registration Process
- Job Opportunities in Industry & Health Authorities
- 13:30-14:30DIA Welcome and Awards CeremonyDIA Distinguished Career and
Outstanding Services Awards Ceremony
- 14:30-15:30 - Plenary Session Part 1
EU INNOVATION AND COMPETITIVENESSIntroduction by the Programme Co-Chairpersons
Iman Barilero, Johnson & Johnson PRD, UK
Marie Dray, International Regulatory Affairs Group, USA
Key Note Speakers:Georgette Lalis,European Commission,
DG Enterprise and Industry, Belgium Jean-Franois Dehecq,sanofi-aventis, France
- 16:00-17:30
Plenary Session Part 2
EU INNOVATION AND COMPETITIVENESS:
PRACTICAL IMPLICATIONS FOR AND
INVOLVEMENT OF THE STAKEHOLDERSModerators:
Iman Barilero, Johnson & Johnson PRD, UK and
Philip Brown, SCRIP, UKPanelists:
Thomas Lonngren, EMEA, EU
Martin Terberger, European Commission, Belgium
Jean Marimbert, AFSSAPS, France
Yann Le Cam, EURORDIS, France
18:00-21:00
Buffet Reception
March 7, 2006
- Late breaking news:
Addition to EuroMeeting Programme,
Tuesday, March 7
13:00-13:45
Special Session:
An Assessment of the Community System of Pharmacovigilance
Session Moderator: Marie A. Dray
Speaker: Peter Arlett, MD, European Commission, Europe
The European Commission-sponsored study An Assessment of the Community System of Pharmacovigilance was made public in February 2006 and the Commission has launched a public consultation on its results including an invitation to comment on the strengths and weaknesses of the Community System. As part of this consultation, Dr. Arlett will present the study report and attendees will be invited to make comments and pose questions on the Community System of Pharmacovigilance.
- 09:00-18:30
Poster Session/Student Poster Session
Posters selected by the review committee, addressing similar topics to those in the programme, will be on display in the exhibition area. Presenters will make themselves available to discuss their work during the coffee and lunch breaks on Tuesday at Le Palais des Congres.The poster review committee will select the three best student posters, and the winning authors will receive a EuroMeeting Student Poster Prize. The Prizes will be awarded at the student poster award ceremony on Tuesday, March 7, at 17:30 by the DIA booth in the exhibition area.
- 18:30-20:00
French Agency Satellite Meeting
THE INVOLVEMENT OF FRANCE IN THE EUROPEAN NETWORKS FOR EVALUATION AND MONITORING OF HEALTH PRODUCTSGeneral Presentation of AFSSAPS:Missions and Goals - Risk Assessment and Management
Jean Marimbert, AFSSAPS, FranceRound Table Discussion on the Common Vision on Clinical Trials in France with Representatives of LEEM, INSERM and AFSSAPS**If you are registered for the EuroMeeting, then you will have access to enter in the satellite meeting without registering separately.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Zerlasiran Achieves Significant Sustained Reduction in Lipoprotein(a) Levels with Infrequent Dosing
November 20th 2024Zerlasiran, a novel siRNA therapy, demonstrated over 80% sustained reductions in lipoprotein(a) levels with infrequent dosing in the Phase II ALPACAR-360 trial, highlighting its potential as a safe and effective treatment for patients at high risk of cardiovascular disease.
